Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 3, 2008, Pages 212-217

  Rami, L ^a,b   Caprile, C ^a,b   Gomez Anson B ^a   Sanchez Valle R ^a   Monte, G C ^b   Bosch, B ^a,b   Molinuevo, J L ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Fundacio Clinic Per a la Recerca Biomedica   (Spain)

Author keywords

Alzheimer's disease; Frontotemporal lobar degeneration; Language deficit; Mild cognitive impairment

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN METABOLISM; COGNITION; COGNITIVE DEFECT; CONTROL GROUP; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HUMAN; LANGUAGE TEST; MAJOR CLINICAL STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFORMANCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX; TEMPORAL LOBE; VERBAL BEHAVIOR; VERBAL MEMORY; VISION; VISUAL MEMORY;

AGED; AMNESIA; ANOMIA; ASPARTIC ACID; CHOLINE; COGNITION DISORDERS; CREATINE; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 40549140105     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113728     Document Type: Article

References (38)

1. Hodges JR, Patterson K: Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia 1995;33:441-459.
2. Brambati SM, Myers D, Wilson A, Rankin KP, Allison SC, Rosen HJ, Miller BL, Gorno-Tempini ML: The anatomy of category-specific object naming in neurodegenerative diseases. J Cogn Neurosci 2006;18:1644-1653.
3. Damasio H, Grabowski T, Tranel D, Hichwa R, Damasio A: A neural basis for lexical retrieval. Nature 1996;380:499-505.
4. Martin A, Wiggs C, Ungerleider L, Haxby J: Neural correlates of category-specific knowledge. Nature 1996;379:649-652.
5. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR: A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000;47:36-45.
6. Perani D, Schnur T, Tettamanti M, Gorno-Tempini M, Cappa SF, Fazio F: Word and picture matching: a PET study of semantic category effects. Neuropsychologia 1999;37: 293-306.
7. Baldo JV, Schwartz S, Wilkins D, Dronkers NF: Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc 2006;12:896-900.
8. Valenzuela M, Sachdev P: Magnetic resonance spectroscopy in AD. Neurology 2001; 56:592-598.
9. Coulthard E, Firbank M, English P, Welch J, Birchall D, O'Brien J, Griffiths TD: Proton magnetic resonance spectroscopy in frontotemporal dementia. J Neurol 2006;253:861-868.
10. Rose SE, de Zubicaray GI, Wang D, Galloway GJ, Chalk JB, Eagle SC, Semple J, Doddrell DM: A 1 H-MRS study of probable Alzheimer's disease and normal aging: implication for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999;17: 291-299.
11. Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR: 1 H-MRS magnetic resonance spectroscopy, cognitive function, and apolipropotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 2002;8:934-942.
12. Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y: Correlation of regional proton magnetic resonance spectrocopy metabolic changes with cognitive deficits in mil Alzheimer disease. Arch Neurol 2002; 59:995-962.
13. Waldman AD, Rai GS: The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology 2003;45:507-512.
14. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP: Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384:23-28.
15. Peña-Casanova J, Guardia J, Bertran-Serra I, Manero RM, Jarne A: Shortened version of the Barcelona test (I): subtests and normal profiles. Neurologia 1997;12:99-111.
16. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58: 1985-1992.
17. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51: 1546-1554.
18. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
20. Golden CJ, Hammeke TA, Purisch AD: The Luria-Nebraska Neuropsychological Battery. Los Angeles, Western Psychological Services, 1980.
21. Rami L, Serradell M, Bosch B, Villar A, Molinuevo JL: Test digital de percepción (TDP) para la valoración de trastornos perceptivos incipientes en la enfermedad de Alzheimer inicial. Neurología 2007;22:342-347.
22. Reitan RM: Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
23. Kaplan E, Goodglass H, Weintraub S: Boston Naming Test. Philadelphia, Lea and Febiger, 1983.
24. Garcia-Albea JE, Sanchez-Bernardos ML, del Viso-Pabon S: Test de Boston para el diagnóstico de la afasia: adaptación española; in Goodglass H, Kaplan E: La Evaluación de la Afasia y de Trastornos Relacionados, ed 2. Madrid, Editorial Médica Panamericana, 1986, pp 129-198.
25. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders, ed 2. Philadelphia, Lea and Febiger, 1983.
26. Jessen F, Block W, Träber F, Keller E, Flacke S, Papassotiropoulus A, Lamerichs R, Heun R, Schild HH: Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000;55:684-688.
27. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO: In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 1999;56:185-192.
28. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF: In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:1313-1322.
29. Mummery CJ, Patterson K, Wise RJ, Vandenbergue R, Price CJ, Hodges JR: Disrupted temporal lobe connections in semantic dementia. Brain 1999;122:61-73.
30. Chan D, Fox NC, Scahill RI, Crum WR, Witwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN: Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001;49: 433-442.
31. Galton CJ, Patterson K, Graham K, Lambon-Ralph MA, Williams G, Antoun N, Sahakian BJ, Hodges JR: Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 2001;5:216-225.
32. Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ: Cinguloparietal atrophy distinguishes Alzheimer's disease from semantic dementia. Arch Neurol 2003;60:949-956.
33. Rami L, Gómez-Anson B, Sanchez-Valle R, et al: Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features. Dement Geriatr Cogn Disord 2007;24:402-410.
34. Troyer AK, Moscovitch M, Winocur G: Clustering and switching as two components of verbal fluency: evidence from younger and older healthy adults. Neuropsychologia 1997;11:138-146.
35. Hirshorn EA, Thompson-Schill SL: Role of the left inferior frontal gyrus in covert word retrieval: neural correlates of switching during verbal fluency. Neuropsychologia 2006; 44:2547-2557.
36. Janowsky JS, Shimamura AP, Kritchevsky M, Squire LR: Cognitive impairment following frontal lobe damage and its relevance to human amnesia. Behav Neurosci 1989;103: 548-560.
37. Parks RW, Loewenstein DA, Dodrill KL, Barker WW, Yoshii F, Chang JY, Emran A, Apicella A, Sheramata WA, Duara R: Cerebral metabolic effects of a verbal fluency test: a PET scan study. J Clin Exp Neuropsychol 1988;10:565-575.
38. Perret E: The left frontal lobe of man and the suppression of habitual responses in verbal categorical behavior. Neuropsychologia 1974;12:323-330.